News |
| |
Esolok
(Esomeprazole 20mg Capsule) is now bioequivalent
to the research brand of AstraZeneca, USA |
Recently, a bioequivalent study
has been done under the supervision of Professor
Dr. Abul Hasnat, Department of Clinical Pharmacy
and Pharmacology, University of Dhaka on two
esomeprazole 20mg capsule (Esolok of The IBN
SINA Pharmaceutical Industry Ltd.. Bangladesh
and Nexium, the research brand of AstraZeneca,
USA) formulations.
The study showed that, both
the brands are bioequivalent in terms of rate
and extent of absorption and serum concentration
throughout the study.
|
| See
details... |
| |
| Price Sensitive Information
|
| |
| Un-audited Half-Yearly
Financial Report for the Year-2011 (From 01-01-2011
to 30-06-2011) |
As per requirements
of the Securities & Exchange Commission’s
(SEC) Notification No. SEC/CMRRCD/2008-183/Admin/03-34
dated September 27, 2009, we are pleased to publish
the Un-audited Half-Yearly Financial Report for
the year 2010 (for the period from 01-01-2010
to 30-06-2010) for our honorable share holders
and stake holders. |
|
| |
| National
Conference 2009 |
 |
The
National Conference of the IBN SINA Pharmaceutical
Industry was held on 26th January, 2009
in Bangladesh- China Friendship Conference
Center.
The
conference was started through holy Quran.
Managing Director of the company Jb. Professor
A.N.M.A. Zaher inaugurated the conference.
|
Among others Marketing Director Mir Quasem
Ali, Finance Director Commodore (Retd.)
M.A. Rahman, Director Professor Dr. Matiur
Rahman, Director Dr. Md. Idris Ali, Deputy
Managing Director Jb. Abdur Raquib and company
secretary Jb. Md. Shahid Farooqui delivered
their speech. The Managing Director and
other directors said that The IBN SINA Pharmaceutical
Industry achieved a praise worthy increment
in sales and touched the milestone of 100
crore. The Directors thanked the field forces
and advised them to make the theme “Come,
Let us change the dimension” to be
real through mutual co-operation and competitive
intension. Marketing Manager Md. Nurullah
presented the sales performance 2008 and
highlighted the marketing strategies for
2009. He also ensured the field forces to
provide all facilities as per requirement
to achieve better performance. All field
forces and high officials of the IBN SINA
Pharmaceutical Industry were present. |
|
| |
